Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2010
11/03/2010EP1863477B1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
11/03/2010EP1220838B1 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds
11/03/2010CN101878203A Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
11/03/2010CN101878202A Gamma secretase modulators
11/03/2010CN101878199A 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
11/03/2010CN101875652A Triazole derivative, and light-emitting element, light-emitting device, lighting device, and electronic device using triazole derivative
11/03/2010CN101875636A Imidazoline-2,4-diketone derivative and preparation method and applications thereof
11/02/2010US7825264 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
11/02/2010US7825256 Inducible nitric oxide synthase dimerization inhibitors
11/02/2010US7825155 Oxindole derivative as feeding control agent
11/02/2010US7825152 Organic compounds and their uses
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825128 such as N-(ethoxycarbonyl)-S-(4-{[4-{[(R)-2-hydroxy-1-methylethyl]amino}-5-(2-thienyl)pyrimidine-2-yl]amino}phenyl)-S-methylsulfoximide, used for the treatment of breast cancer and rheumatoid arthritis
11/02/2010US7825124 Indolylmaleimide derivatives
11/02/2010US7825122 Diaza heterocyclic sulfonamide derivatives and their uses
11/02/2010US7825121 useful as selective CCR5 antagonists; use of a combination of a CCR5 antagonist of this invention and one or more antiviral or other agents in the treatment of HIV
11/02/2010US7825116 N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines
11/02/2010US7825115 Protein kinase inhibitors; antitumor agents; such as 5-methyl-1-quinol-4-ylmethyl-3-(4-trifluoromethanesulfonylphenyl)imidazolidine-2,4-dione trifluoroacetate
11/02/2010CA2545527C Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
11/02/2010CA2436361C Angiotensin ii antagonistic compound for use as analgesic and antiinflammatory agent
11/02/2010CA2413971C Heterocyclic hydrazones as novel anti-cancer agents
11/02/2010CA2400167C Insecticidal anthranilamides
10/2010
10/28/2010WO2010124121A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
10/28/2010WO2010124119A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124114A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124108A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124102A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124097A2 Transcription factor modulating compounds and methods of use thereof
10/28/2010WO2010124086A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010123956A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010WO2010123919A2 Piperidine inhibitors of janus kinase 3
10/28/2010WO2010123451A1 Sulphide bridged derivatives as modulators of mglur5
10/28/2010WO2010123017A1 Tetrazole compound
10/28/2010WO2010123006A1 Pyrrolidine compound
10/28/2010WO2010122927A1 Pharmaceutical agent for prevention or treatment of retarded nerve regeneration induced by diabetes
10/28/2010WO2010122171A1 5-heteroarylmethyl-i- (b-mercapto- [1,2, 4 -triazolylmethyl) -cyclopentanol as fungicides
10/28/2010WO2010122162A1 Diaryl ethers
10/28/2010WO2010122151A1 3 -azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010WO2010122038A1 Inhibitors of bruton's tyrosine kinase
10/28/2010WO2010121918A1 Proline derivatives as cathepsin inhibitors
10/28/2010WO2010121673A1 Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole
10/28/2010WO2010068049A3 Process for preparing (r)-(+)-lansoprazole and intermediate used therein
10/28/2010WO2010065898A3 Egfr kinase knockdown via electrophilically enhanced inhibitors
10/28/2010WO2009142732A3 Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
10/28/2010WO2009140089A8 Sulfone compounds which modulate the cb2 receptor
10/28/2010US20100274023 Novel intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes
10/28/2010US20100274016 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
10/28/2010US20100274005 Bicyclic pyrazole compounds as antibacterial agents
10/28/2010US20100274004 Bicyclic pirazole compounds as antibacterial agents
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273845 Angiotensin ii receptor antagonists
10/28/2010US20100273835 Novel compounds
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds
10/28/2010US20100273814 ((phenyl)imidazolyl)methylheteroaryl compounds
10/28/2010US20100273811 N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and Salts Thereof
10/28/2010US20100273804 Pyridazine derivatives useful as fungicides and for the treatment of cancer
10/28/2010US20100273797 Alpha-ketoamides and derivatives thereof
10/28/2010US20100273796 2-benzylpyridazinone derivatives as met kinase inhibitors
10/28/2010US20100273781 Cxcr3 receptor antagonists
10/28/2010US20100273780 Substituted 8-heteroaryl xanthines
10/28/2010US20100273779 Pyridazinone Derivatives
10/28/2010US20100273774 Indolymaleimide derivatives
10/28/2010US20100273773 Dibenzoazepine and dibenzooxazepine trpa1 agonists
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273745 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010CA2759714A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759713A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759697A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759614A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759547A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759160A1 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010CA2759142A1 Diaryl ethers
10/28/2010CA2759026A1 Piperidine inhibitors of janus kinase 3
10/28/2010CA2758985A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758210A1 Proline derivatives as cathepsin inhibitors
10/28/2010CA2756234A1 Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole
10/28/2010CA2748414A1 Inhibitors of bruton's tyrosine kinase
10/27/2010EP2242752A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
10/27/2010EP2242751A1 Heterocyclic derivatives as hepatitis c virus inhibitors
10/27/2010EP2242750A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors
10/27/2010EP2242740A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments
10/27/2010EP2242739A1 Insecticidal arylpyrrolines
10/27/2010EP2007735B1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
10/27/2010EP1891057B1 Azabicyclo[3.1.0]hexane derivaives as dopamin d3 receptor modulators
10/27/2010EP1539710B1 Heterocyclic derivatives
10/27/2010CN1993356B Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
10/27/2010CN101870692A Novel piperazinyl pyridazine compounds
10/27/2010CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/26/2010US7820861 chemical intermediate for a sulfonanilide of 4,6-dimethoxypyrmidine derivative herbicide
10/26/2010US7820824 As labeling reagents for a variety of biological applications
10/26/2010US7820821 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820818 Inhibitors of cathepsin K; inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors; 4-Cyclopentylamino-5-(4-phenyl-but-1-ynyl)-pyrimidine-2-carbonitrile; 5-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-prop-1-ynyl]-4-(2,2-dimethyl-propylamino)-pyrimidine-2-carbonitrile
10/26/2010US7820817 substituted piperazine compounds that are useful modulators of muscarinic receptors; 1-(5-bicyclo[2.2.1]hept-2-enylmethyl)-4-(3-nitro-2-pyridyl)-piperazine; treatment of COPD, asthma, urinary incontinence, glaucoma, Alzheimer's (AchE inhibitors), and pain
10/26/2010US7820704 Substituted heteroaryl derivatives, compositions, and methods of use
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 626